目的:观察清肝止晕汤在肝阳上亢型眩晕方面的临床疗效。方法:收集2014年2月—2016年2月间本院收治的肝阳上亢型眩晕症患者80例,随机分为治疗组和对照组,每组患者均40例。对照组患者给予天麻素注射液0.5 g,加入5%葡萄糖250 m L,静滴,治...目的:观察清肝止晕汤在肝阳上亢型眩晕方面的临床疗效。方法:收集2014年2月—2016年2月间本院收治的肝阳上亢型眩晕症患者80例,随机分为治疗组和对照组,每组患者均40例。对照组患者给予天麻素注射液0.5 g,加入5%葡萄糖250 m L,静滴,治疗组患者给予自拟清肝止晕汤口服,两组均2周为1个疗程。结果:治疗组患者的治疗有效率92%明显高于对照组患者的治疗有效率68%,差异为显著性差异(P<0.05),有统计学意义。结论:清肝止晕汤治疗肝阳上亢型眩晕能够取得更加有效的治疗效果,在临床上值得推广应用。展开更多
Objective To observe the effect of three vertigo-stopping needles on the contents of neuropeptide Y （NPY）, endothelin （ET） and calcitonin gene-related peptide （CGRP） in plasma of patients with cervical vertigo, ...Objective To observe the effect of three vertigo-stopping needles on the contents of neuropeptide Y （NPY）, endothelin （ET） and calcitonin gene-related peptide （CGRP） in plasma of patients with cervical vertigo, and to explore its mechanism of treatment. Methods One hundred and eighty patients with cervical vertigo were divided into group A [acupuncture at R6nyfng （人迎ST 9） and Fengchi （风池 GB 20）, and frontal line], group B [acupuncture at Jing jiaji （颈夹脊）, GB 20 and Baihui （百会 GV 20）] and group C [intravenous infusion with ligustrazine and oral administration with flunarizine] according to simple randomization, with 60 cases in each group. For the patients in group A and group B, the treatment was conducted once a day, and ten times were considered as one course of treatment. Two days were free of treatment between two courses, and two courses were needed. For the patients in group C, the treatment was conducted for fifteen days. The contents of NPY, ET and CGRP in plasma before and after treatment were detected in patients with cervical vertigo. Results The contents of NPY in plasma of patients in the three groups after treatment were markedly lower than that before treatment （all P〈0.01）, and the differences were not statistically significant when compared the descending degrees among three groups （P〉0.05）. The contents of ET in plasma of patients in the three groups after treatment were markedly lower than that before treatment （P〈0.05, P〈0.01）, the descending degree in group A was greater than that in group B and group C, and the difference was statistically significant （P〈0.O1, P〈O.05）; while the difference was not statistically significant when compared the descending degrees between group B and group C （P〉0.05）. The contents of CGRP in plasma of patients in the three groups after treatment were markedly higher than that before treatment （P〈0.05, P〈O.O1）, the increasing degree in group A was greater than that in group B a展开更多
文摘目的:观察清肝止晕汤在肝阳上亢型眩晕方面的临床疗效。方法:收集2014年2月—2016年2月间本院收治的肝阳上亢型眩晕症患者80例,随机分为治疗组和对照组,每组患者均40例。对照组患者给予天麻素注射液0.5 g,加入5%葡萄糖250 m L,静滴,治疗组患者给予自拟清肝止晕汤口服,两组均2周为1个疗程。结果:治疗组患者的治疗有效率92%明显高于对照组患者的治疗有效率68%,差异为显著性差异(P<0.05),有统计学意义。结论:清肝止晕汤治疗肝阳上亢型眩晕能够取得更加有效的治疗效果,在临床上值得推广应用。
基金Supported by:Department of Science and Technology of Guizhou ProvinceQKHLS[2012]No.049
文摘Objective To observe the effect of three vertigo-stopping needles on the contents of neuropeptide Y （NPY）, endothelin （ET） and calcitonin gene-related peptide （CGRP） in plasma of patients with cervical vertigo, and to explore its mechanism of treatment. Methods One hundred and eighty patients with cervical vertigo were divided into group A [acupuncture at R6nyfng （人迎ST 9） and Fengchi （风池 GB 20）, and frontal line], group B [acupuncture at Jing jiaji （颈夹脊）, GB 20 and Baihui （百会 GV 20）] and group C [intravenous infusion with ligustrazine and oral administration with flunarizine] according to simple randomization, with 60 cases in each group. For the patients in group A and group B, the treatment was conducted once a day, and ten times were considered as one course of treatment. Two days were free of treatment between two courses, and two courses were needed. For the patients in group C, the treatment was conducted for fifteen days. The contents of NPY, ET and CGRP in plasma before and after treatment were detected in patients with cervical vertigo. Results The contents of NPY in plasma of patients in the three groups after treatment were markedly lower than that before treatment （all P〈0.01）, and the differences were not statistically significant when compared the descending degrees among three groups （P〉0.05）. The contents of ET in plasma of patients in the three groups after treatment were markedly lower than that before treatment （P〈0.05, P〈0.01）, the descending degree in group A was greater than that in group B and group C, and the difference was statistically significant （P〈0.O1, P〈O.05）; while the difference was not statistically significant when compared the descending degrees between group B and group C （P〉0.05）. The contents of CGRP in plasma of patients in the three groups after treatment were markedly higher than that before treatment （P〈0.05, P〈O.O1）, the increasing degree in group A was greater than that in group B a
